Abstract

For thousands of years, it has been widely believed that walnut is a kind of nut that has benefits for the human body. Walnut oil, accounting for about 70% of walnut, mainly consists of polyunsaturated fatty acids. To investigate the effect of walnut oil on memory impairment in mice, scopolamine (3 mg/kg body weight/d) was used to establish the animal model during Morris Water Maze (MWM) tests. Walnut oil was administrated orally at 10 mL/kg body weight/d for 8 consecutive weeks. The results showed that walnut oil treatment ameliorated the behavior of the memory-impaired mice in the MWM test. Additionally, walnut oil obviously inhibited acetylcholinesterase activity (1.26 ± 0.12 U/mg prot) (p = 0.013) and increased choline acetyltransferase activity (129.75 ± 6.76 U/mg tissue wet weight) in the brains of scopolamine-treated mice (p = 0.024), suggesting that walnut oil could prevent cholinergic function damage in mice brains. Furthermore, walnut oil remarkably prevented the decrease in total superoxide dismutase activity (93.30 ± 5.50 U/mg prot) (p = 0.006) and glutathione content (110.45 ± 17.70 mg/g prot) (p = 0.047) and the increase of malondialdehyde content (13.79 ± 0.96 nmol/mg prot) (p = 0.001) in the brain of scopolamine-treated mice, indicating that walnut oil could inhibit oxidative stress in the brain of mice. Furthermore, walnut oil prevented histological changes of neurons in hippocampal CA1 and CA3 regions induced by scopolamine. These findings indicate that walnut oil could prevent memory impairment in mice, which might be a potential way for the prevention of memory dysfunctions.

Highlights

  • Alzheimer’s disease (AD) is one of the most common causes of dementia with a progressive and fatal neurodegenerative disorder in the elderly [1]

  • This study aimed to investigate whether walnut oil could prevent cognitive impairment and memory deficits induced by scopolamine

  • The SCOP group took a longer time to find the platform than the CON group from the second day to the fourth day of the training period, showing that SCOP treatment could cause significant cognitive dysfunction in mice

Read more

Summary

Introduction

Alzheimer’s disease (AD) is one of the most common causes of dementia with a progressive and fatal neurodegenerative disorder in the elderly [1]. Cholinesterase inhibitors (ChEIs) have been the main approach to symptomatic treatment [6] and could help to enhance cholinergic neurotransmission by inhibiting excessive hydrolysis of acetylcholine (ACh) by acetylcholinesterase (AChE). These drugs’ therapeutic results are usually modest and the duration of effect and long-term safety are unknown [7]. Potential benefits of nutritional supplementation with polyunsaturated fatty acid-rich plant foods have been suggested in neurodegenerative and inflammatory diseases including

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call